YOLFTbeta
Binh Dinh Pharmaceutical and Medical Equipment JSC

Binh Dinh Pharmaceutical and Medical Equipment JSC

DBD · VN · Healthcare / Drug Manufacturers - Specialty & Generic

44,500.00VND+850.00 (+1.95%)

Price History

Full chart

Market Stats

Previous Close43,650.00
Open44,000.00
Day Range43,900.00 – 44,950.00
52-Week Range43,050.00 – 52,229.17
Volume14.80K
Market Cap4.17T
P/E (TTM)13.38
Forward P/E0.00
EPS3,299.96
Dividend Yield4.37%
Beta-0.04
50-Day Avg46,805.00
200-Day Avg49,910.00

About

Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company manufactures and trades in pharmaceuticals and medical equipment in Vietnam. It offers antibiotics; anticancer drugs; hemodialysis solutions; hepatobiliary drugs; analgesic and antipyretic drugs; drugs for muscles, bones, and joints; antihistamine anti-allergy drugs; ear, eye, nose, and throat drops; cardiovascular drugs; nervous system drugs; vitamins and minerals; endocrine hormones; respiratory drugs; antifungal and antiviral drugs; dermatologic drugs; antidotes; and drugs for treating lipid disorders. The company also provides automatic herbal medicine brewing stoves, distilled water tanks, hand sanitizers, medical solid waste incinerators, water distillers, washing machines, eye drop bottle washing machines, clothes dryers, autoclave machines, and drying and microclimate cabinets. In addition, it engages in the wholesale and retail sale of medicines, medicinal herbs, and medical equipment; and production of medicines, and medical chemicals and herbs. The company was founded in 1976 and is based in Quy Nhon, Vietnam.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMs. Huong Thi Thanh Pham
  • Employees1.38K
  • Headquarters498 Nguyen Thai Hoc Street, Quy Nhon, Vietnam, Vietnam
  • Websitehttps://bidiphar.com

Leadership

  • Ms. Huong Thi Thanh PhamCEO, GM, Director & Member of Executive Board · b. 1965
  • Mr. Dung Ngoc NguyenDeputy GM of Sales, Director & Member of Executive Board · b. 1969
  • Ms. Quynh Ngoc Thi BanhDeputy GM of Production & Member of Executive Board · b. 1969
  • Mr. Phuong Huy DoChief Accountant · b. 1982
  • Ms. Linh Thi My HuynhCompany Secretary & Corporate Governance Officer · b. 2000

Financials

Income Statement

Currency: VND2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-1.26T1.56T1.55T1.65T1.73T1.87T
Growth (%)--+23.99%-0.24%+6.24%+4.59%+7.98%
Cost of Revenue-765.81B935.94B787.17B853.25B894.98B981.00B
Gross Profit-491.14B622.57B767.65B798.52B832.57B884.38B
Gross Margin-39.07%39.95%49.37%48.34%48.19%47.41%
Operating Expense-309.36B405.44B494.31B501.54B528.98B558.10B
Operating Income-181.78B217.13B273.34B296.98B303.59B326.28B
Operating Margin-14.46%13.93%17.58%17.98%17.57%17.49%
EBITDA---346.85B373.05B377.31B400.95B
EBITDA Margin---22.31%22.59%21.84%21.49%
Net Income-157.86B189.12B243.56B269.05B275.18B291.94B
Net Income Margin-12.56%12.13%15.66%16.29%15.93%15.65%
Interest Expense-6.59B1.32B6.62B7.00B4.06B3.85B
Interest Expense % of Total Revenue-0.52%0.08%0.43%0.42%0.23%0.21%

Balance Sheet

Currency: VND2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-1.44T1.56T1.90T1.99T2.26T2.58T
Total Liabilities-448.78B418.97B540.58B556.07B603.07B862.89B
Total Equity-988.63B1.14T1.36T1.43T1.66T1.72T
Cash-108.73B69.27B55.56B87.84B314.20B202.78B
Net Debt103.68B-27.76B20.44B---

Cash Flow

Currency: VND2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.04B212.91B117.57B165.01B293.99B264.73B615.19B
Investing Cash Flow-19.25B-2.14B-95.23B-157.69B---
Financing Cash Flow65.89B-240.20B-61.80B-21.03B---
Capital Expenditure149.63B59.73B54.64B82.83B133.69B148.75B408.57B
Free Cash Flow-153.17B62.93B82.18B160.30B115.99B206.61B
Dividends Paid78.53B78.55B75.55B-149.70B9.93M185.63B
FCF to OCF-71.94%53.53%49.81%54.52%43.81%33.59%
Dividend Paid to FCF-51.28%120.05%-93.39%0.01%89.84%

Earnings

Report DateJun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jul 25, 2023Nov 14, 2023Dec 31, 2023May 2, 2024Jul 26, 2024Oct 29, 2024Jan 22, 2025Apr 28, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------------------
EPS Actual440.67481.80385.90368.45407.46345.19384.98438.47402.51518.98353.35407.79598.38439.81522.22547.18636.29577.19846.56731.49959.73718.46632.27717.74967.24801.90647.99865.91965.61634.03629.63849.81943.73
Surprise---------------------------------
Timing--------------------After-hoursPre-market-Pre-marketAfter-hoursAfter-hoursAfter-hoursPre-market-----

Key Statistics & Ratios

Market Cap4.17T
Enterprise Value4.07T
Trailing P/E13.38
Forward P/E0.00
Price / Sales2.21
Price / Book2.50
EPS3,299.96
Book Value18,372.23
Revenue (TTM)1.89T
Gross Profit (TTM)864.61B
EBITDA365.61B
Profit Margin16.65%
Operating Margin19.22%
Return on Equity17.84%
Return on Assets7.73%
Shares Outstanding94.49M
Shares Float81.00M
Beta-0.04
Dividend Yield4.37%
Dividend Rate2,000.00
Payout Ratio82.54%

Dividends

20261×
2000.00Aug 27, 2026
20251×
2000.00Jun 30, 2025
20231×
1600.00Mar 22, 2023
20211×
839.16Mar 15, 2021
20201×
839.16Mar 23, 2020
20191×
839.16Mar 19, 2019

Stock Splits

  • Jun 19, 20245:4
  • Jun 9, 202213:10
  • Jun 14, 202111:10